Document is current
Any future updates will be listed below
-
Authors
Wang, Rong http://orcid.org/0000-0002-0465-9561
Yamada, Tadaaki http://orcid.org/0000-0002-6945-281X
Kita, Kenji http://orcid.org/0000-0002-4622-6633
Taniguchi, Hirokazu http://orcid.org/0000-0003-2414-8344
Arai, Sachiko
Fukuda, Koji
Terashima, Minoru http://orcid.org/0000-0002-5688-5181
Ishimura, Akihiko http://orcid.org/0000-0002-3127-0404
Nishiyama, Akihiro
Tanimoto, Azusa http://orcid.org/0000-0002-6643-3867
Takeuchi, Shinji http://orcid.org/0000-0002-3779-1454
Ohtsubo, Koshiro
Yamashita, Kaname
Yamano, Tomoyoshi http://orcid.org/0000-0001-8849-6239
Yoshimura, Akihiro http://orcid.org/0000-0002-3753-2110
Takayama, Koichi
Kaira, Kyoichi http://orcid.org/0000-0001-5548-7686
Taniguchi, Yoshihiko http://orcid.org/0000-0001-6387-3683
Atagi, Shinji http://orcid.org/0000-0003-1876-7069
Uehara, Hisanori
Hanayama, Rikinari http://orcid.org/0000-0003-2102-3386
Matsumoto, Isao http://orcid.org/0000-0002-3335-1013
Han, Xujun http://orcid.org/0000-0002-4049-4039
Matsumoto, Kunio http://orcid.org/0000-0002-6532-4482
Wang, Wei http://orcid.org/0000-0001-8887-8499
Suzuki, Takeshi
Yano, Seiji http://orcid.org/0000-0002-6151-2988
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (16cm0106513h0001)
Japan Society for the Promotion of Science (JP16H05308)
Research grants from Boehringer-Ingelheim, Eisai, and MSD, and Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University.
-
License Information
Text and Data Mining valid from 2020-09-14
Version of Record valid from 2020-09-14
-
More Information
Article History
Received: 26 December 2019
Accepted: 24 August 2020
First Online: 14 September 2020
Competing interests
: Y.T. obtained honoraria from Chugai Pharma, AstraZeneca, and Boehringer-Ingelheim. T. Yamada obtained research grants from Ono Pharma, Chugai Pharma, Pfizer Co, and Takeda Pharma. K. Kaira obtained research grants from AstraZeneca, and honoraria from Ono Pharma, Eli Lilly, Chugai Pharma, AstraZeneca, and Boehringer-Ingelheim. S.A. obtained grants and personal fees from Chugai, grants and non-financial support from F. Hoffmann-La Roche, grants and personal fees from Boehringer Ingelheim, grants and personal fees from AstraZeneca. S.Y. obtained research grants and honoraria from Chugai Pharma, AstraZeneca, and Boehringer-Ingelheim. The other authors have no conflict of interest.
